ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2727

Evaluating Psoriatic Arthritis and Psoriasis Skin Lesions: Ultrasound As a Complementary Measure

Yogan Kisten1, Per T Larsson2, Erik af Klint2, Hamed Rezaei2,3, Noémi Györi1, Liv Eidsmo4, Mona Ståhle4 and Ronald F. van Vollenhoven1,5, 1Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 2Medicine, Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 3Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 4Dermatology and Venereology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 5Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Inflammation, management, psoriasis, Psoriatic arthritis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The diagnosis and assessment of psoriatic arthritis (PsA) and psoriasis (PsO) lesions are mostly done by visual inspection, and when in doubt, supplemented by a biopsy. Although PsA is primarily assessed by physical examination, the utility of ultrasound is beneficial. Here, we test the performance of advanced ultrasound skin imaging software applications in PsO & PsA assessment.

Methods: The rheumatologist and dermatologist performed standard clinical examinations on PsA and PsO patients respectively. Using ultrasound (US), we evaluated the hand, wrist, & symptomatic joints of PsA patients for synovitis & tenosynovitis (nail beds included). Blinded by the clinical results & treatment plans, the epidermal, dermal and subcutaneous tissue thickness of 2 of the most affected lesions were scanned by high frequency B-Mode, automated color Doppler quantification (CDQ) and elastography applications (measuring lesion size, depth, hyperemia and tissue elasticity). The skin tissues adjacent to the psoriatic lesion, and the unaffected skin on the contralateral side (self-control) were measured for comparison.

Results: A total of 270 skin measurements in, around, & opposite to the 10 psoriatic lesions of 5 PsA/PsO patients were analyzed. Epidermal thickness differed significantly between adjacent and control tissue layers [F (2,27) = 30.95, MSE = 0.76, p<0.001]. Similar findings were evident for dermal thickness differences [F (2,27) = 5.05, MSE = 1.59, p=0.014]. Subcutaneous tissue depths were of no significance. Ultrasound CDQ & elastography revealed hyperemia in 80% of lesions (60% with plaque). Contrary, 20% of lesions showed no obvious Doppler activity, displaying reduced tissue stiffening on elastography (suggesting healed lesions). Two of 10 lesions were soft on elastography (no acoustic shadows) but had low-level CDQ activity (minimum 0.016:0.034  & maximum 0.103:0.135 ratios). In PsA patients, the presence of synovitis (intra &extra-articular Doppler) mostly in DIPs & PIPs, and tenosynovitis of flexor tendons were detected. Hyperemic nail beds (altered microcirculation) and hand psoriasis skin perfusion was evident on US, and confirmed by fluorescence optical imaging (FOI).

Conclusion: Several ultrasound parameters clearly distinguish between affected & normal skin and could be used as quantitative and objective measures in assessing psoriasis lesions. Some US parameters appear to distinguish between adjacent (non-involved) skin & self-control skin, while some show striking heterogeneity between different patients, suggesting that US may help subtype psoriasis lesions, but need to be investigated further. Ultrasound metrics of skin tissue (depth, plaque characteristics, elasticity and Doppler quantification) has potential to compliment the clinical assessment of PsO & PsA patients.


Disclosure: Y. Kisten, None; P. T. Larsson, None; E. af Klint, None; H. Rezaei, None; N. Györi, None; L. Eidsmo, None; M. Ståhle, None; R. F. van Vollenhoven, •AbbVie, Amgen, BMS, GSK, Pfizer, Roche, UCB, 2,AbbVie, Biotest, BMS, Celgene, Crescendo, GSK, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, UCB, Vertex, 5.

To cite this abstract in AMA style:

Kisten Y, Larsson PT, af Klint E, Rezaei H, Györi N, Eidsmo L, Ståhle M, van Vollenhoven RF. Evaluating Psoriatic Arthritis and Psoriasis Skin Lesions: Ultrasound As a Complementary Measure [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/evaluating-psoriatic-arthritis-and-psoriasis-skin-lesions-ultrasound-as-a-complementary-measure/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-psoriatic-arthritis-and-psoriasis-skin-lesions-ultrasound-as-a-complementary-measure/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology